title: Reoperation for adrenocortical neoplasms.
abstract: Adrenocortical cancer is a highly lethal malignancy. Surgical resection remains the only potential modality for cure or appreciable disease-free intervals. Even with radical resection, most patients will recur or have metastatic disease. For these patients, surgical re-resection of local recurrence and metastases is the best chance of controlling disease and prolonging survival. Patients with widely metastatic disease or those with tumors not amenable to re-resection may benefit from tumor debulking to help control symptoms associated with oversecretion syndromes. No currently available regimen of chemotherapy, including mitotane, and/or radiotherapy achieves significant cure or response rates. Multiple promising treatments such as radiofrequency ablation, tyrosine kinase inhibitors, and competitive inhibitors of multidrug resistance gene products are in preclinical trials and may improve patient outcomes.
authors.affiliation: Department of Surgery, San Francisco Medical Center, University of California, 4150 Clement Street, 94121, USA. duhq@surgery.ucsf.edu
authors.forename: James A
authors.initials: JA
authors.lastname: Lee
authors.forename: Quan-Yang
authors.initials: QY
authors.lastname: Duh
mesh_terms: D000306:Adrenal Cortex Neoplasms / Q000601:surgery*; D006801:Humans; D012086:Reoperation